Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Bendszus

Showing results (561-570 of 671) with videos related to

Pageof 68
Sort By:
Stroke|May 20, 2025
Mechanical Thrombectomy for Large Ischemic Stroke: A Critical Appraisal of Evidence From 6 Randomized Controlled TrialsAmrou Sarraj, Shinichi Yoshimura, Götz Thomalla, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 24, 2014
A phase II, randomized, study of weekly APG101+reirradiation versus reirradiation in progressive glioblastomaWolfgang Wick, Harald Fricke, Klaus Junge, et al.
Neuro-Oncology|May 8, 2018
Assessing the predictability of IDH mutation and MGMT methylation status in glioma patients using relaxation-compensated multipool CEST MRI at 7.0 TDaniel Paech, Johannes Windschuh, Johanna Oberhollenzer, et al.
Radiology|September 17, 2016
Radiogenomics of Glioblastoma: Machine Learning-based Classification of Molecular Characteristics by Using Multiparametric and Multiregional MR Imaging FeaturesPhilipp Kickingereder, David Bonekamp, Martha Nowosielski, et al.
Neurological Research and Practice|May 22, 2022
AMPLIFY-NEOVAC: a randomized, 3-arm multicenter phase I trial to assess safety, tolerability and immunogenicity of IDH1-vac combined with an immune checkpoint inhibitor targeting programmed death-ligand 1 in isocitrate dehydrogenase 1 mutant gliomasLukas Bunse, Anne-Kathleen Rupp, Isabel Poschke, et al.
Brain & Spine|November 29, 2023
A randomized, single ascending dose safety, tolerability and pharmacokinetics study of NicaPlant® in aneurysmal subarachnoid hemorrhage patients undergoing clippingJohannes Kerschbaumer, Christian Franz Freyschlag, Ondra Petr, et al.
Neuro-Oncology|October 11, 2017
Radiologic progression of glioblastoma under therapy-an exploratory analysis of AVAglioMartha Nowosielski, Benjamin M Ellingson, Olivier L Chinot, et al.
Biomedicines|September 28, 2023
Post-Surgical Depositions of Blood Products Are No Major Confounder for the Diagnostic and Prognostic Performance of CEST MRI in Patients with GliomaNikolaus von Knebel Doeberitz, Florian Kroh, Laila König, et al.
STAR Protocols|November 6, 2025
u-LINNDA: A protocol for user-optimized lymphoma identification through neural network detection aidMaximilian Fischer, Miriam Cindy Maurer, Robin Peretzke, et al.
Neuro-Oncology Advances|July 10, 2020
Bevacizumab-based treatment as salvage therapy in patients with recurrent symptomatic brain metastasesAnna Sophie Berghoff, Michael Oliver Breckwoldt, Lars Riedemann, et al.
Pageof 68

Showing results (561-570 of 671) with videos related to

Sort By:
Pageof 68
Stroke|May 20, 2025
Mechanical Thrombectomy for Large Ischemic Stroke: A Critical Appraisal of Evidence From 6 Randomized Controlled TrialsAmrou Sarraj, Shinichi Yoshimura, Götz Thomalla, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 24, 2014
A phase II, randomized, study of weekly APG101+reirradiation versus reirradiation in progressive glioblastomaWolfgang Wick, Harald Fricke, Klaus Junge, et al.
Neuro-Oncology|May 8, 2018
Assessing the predictability of IDH mutation and MGMT methylation status in glioma patients using relaxation-compensated multipool CEST MRI at 7.0 TDaniel Paech, Johannes Windschuh, Johanna Oberhollenzer, et al.
Radiology|September 17, 2016
Radiogenomics of Glioblastoma: Machine Learning-based Classification of Molecular Characteristics by Using Multiparametric and Multiregional MR Imaging FeaturesPhilipp Kickingereder, David Bonekamp, Martha Nowosielski, et al.
Neurological Research and Practice|May 22, 2022
AMPLIFY-NEOVAC: a randomized, 3-arm multicenter phase I trial to assess safety, tolerability and immunogenicity of IDH1-vac combined with an immune checkpoint inhibitor targeting programmed death-ligand 1 in isocitrate dehydrogenase 1 mutant gliomasLukas Bunse, Anne-Kathleen Rupp, Isabel Poschke, et al.
Brain & Spine|November 29, 2023
A randomized, single ascending dose safety, tolerability and pharmacokinetics study of NicaPlant® in aneurysmal subarachnoid hemorrhage patients undergoing clippingJohannes Kerschbaumer, Christian Franz Freyschlag, Ondra Petr, et al.
Neuro-Oncology|October 11, 2017
Radiologic progression of glioblastoma under therapy-an exploratory analysis of AVAglioMartha Nowosielski, Benjamin M Ellingson, Olivier L Chinot, et al.
Biomedicines|September 28, 2023
Post-Surgical Depositions of Blood Products Are No Major Confounder for the Diagnostic and Prognostic Performance of CEST MRI in Patients with GliomaNikolaus von Knebel Doeberitz, Florian Kroh, Laila König, et al.
STAR Protocols|November 6, 2025
u-LINNDA: A protocol for user-optimized lymphoma identification through neural network detection aidMaximilian Fischer, Miriam Cindy Maurer, Robin Peretzke, et al.
Neuro-Oncology Advances|July 10, 2020
Bevacizumab-based treatment as salvage therapy in patients with recurrent symptomatic brain metastasesAnna Sophie Berghoff, Michael Oliver Breckwoldt, Lars Riedemann, et al.
Pageof 68